Symbols / ZYBT $0.76 -2.50%
ZYBT Chart
About
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 36.24M |
| Enterprise Value | 140.54M | Income | -19.37M | Sales | 153.74M |
| Book/sh | 0.91 | Cash/sh | 1.00 | Dividend Yield | — |
| Payout | 0.00% | Employees | 277 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.24 | P/B | 0.84 | P/C | — |
| EV/EBITDA | -63.51 | EV/Sales | 0.91 | Quick Ratio | 1.00 |
| Current Ratio | 1.49 | Debt/Eq | 23.49 | LT Debt/Eq | — |
| EPS (ttm) | -0.06 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -34.40% | Earnings | — | ROA | -3.45% |
| ROE | -6.38% | ROIC | — | Gross Margin | 37.37% |
| Oper. Margin | -46.33% | Profit Margin | -12.60% | Shs Outstand | 47.39M |
| Shs Float | 4.42M | Short Float | 0.46% | Short Ratio | 1.13 |
| Short Interest | — | 52W High | 14.30 | 52W Low | 0.68 |
| Beta | — | Avg Volume | 16.17K | Volume | 5.42K |
| Target Price | — | Recom | None | Prev Close | $0.78 |
| Price | $0.76 | Change | -2.50% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.76
Latest analyst target
3. DCF / Fair value
$9.20
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.76
Low
—
High
—
Mean
—
- (ZYBT) Volatility Zones as Tactical Triggers - Stock Traders Daily Mon, 16 Mar 2026 02
- Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating Challenges with Strategic Opportunities in the Veterinary Vaccine Market - DirectorsTalk Interviews Fri, 27 Feb 2026 00
- Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) 26% Share Price Surge Not Quite Adding Up - simplywall.st ue, 28 Oct 2025 07
- Risks Still Elevated At These Prices As Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Shares Dive 79% - 富途牛牛 Sat, 27 Sep 2025 07
- ZYBT Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 16
- Is Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 3.8% Concerning? - Yahoo Finance Sun, 14 Sep 2025 07
- Why Actelis Networks Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket - Benzinga Fri, 03 Oct 2025 07
- Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control - TipRanks ue, 10 Feb 2026 08
- Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%? - Yahoo Finance Mon, 07 Apr 2025 07
- Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO - renaissancecapital.com hu, 22 Aug 2024 07
- ZYBT Stock Price and Chart — NASDAQ:ZYBT - TradingView Mon, 06 Jan 2025 08
- Zhengye Biotechnology Holding Limited Closes Initial Public Offering, Raising $6 Million on Nasdaq - Nasdaq Wed, 08 Jan 2025 08
- Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - thebambooworks.com Mon, 20 Jan 2025 08
- Kyverna Therapeutics (NASDAQ:KYTX) and Zhengye Biotechnology (NASDAQ:ZYBT) Critical Contrast - Defense World Sun, 08 Mar 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 43.46K | 0.00 | 0.00 | -189.14K |
| TaxRateForCalcs | 0.06 | 0.14 | 0.13 | 0.12 |
| NormalizedEBITDA | 41.92M | 72.10M | 85.55M | 71.64M |
| TotalUnusualItems | 679.00K | -10.05M | -968.00K | -1.52M |
| TotalUnusualItemsExcludingGoodwill | 679.00K | -10.05M | -968.00K | -1.52M |
| NetIncomeFromContinuingOperationNetMinorityInterest | 11.31M | 31.46M | 46.73M | 38.96M |
| ReconciledDepreciation | 24.16M | 23.91M | 18.80M | 16.01M |
| ReconciledCostOfRevenue | 95.06M | 94.14M | 112.39M | 88.67M |
| EBITDA | 42.60M | 72.10M | 85.55M | 70.12M |
| EBIT | 18.44M | 48.19M | 66.75M | 54.11M |
| NetInterestIncome | -3.81M | -4.11M | -2.73M | -934.00K |
| InterestExpense | 4.04M | 4.42M | 2.84M | 1.05M |
| InterestIncome | 231.00K | 312.00K | 114.00K | 112.00K |
| NormalizedIncome | 10.68M | 31.46M | 46.73M | 40.29M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 11.31M | 31.46M | 46.73M | 38.96M |
| TotalExpenses | 169.18M | 164.01M | 194.18M | 158.46M |
| TotalOperatingIncomeAsReported | 16.44M | 44.99M | 65.83M | 52.38M |
| DilutedAverageShares | 47.17M | 47.17M | 47.17M | 47.17M |
| BasicAverageShares | 47.17M | 45.67M | 45.67M | 45.67M |
| DilutedEPS | 0.24 | 0.67 | 0.99 | 0.83 |
| BasicEPS | 0.24 | 0.69 | 1.02 | 0.85 |
| DilutedNIAvailtoComStockholders | 11.31M | 31.46M | 46.73M | 38.96M |
| NetIncomeCommonStockholders | 11.31M | 31.46M | 46.73M | 38.96M |
| NetIncome | 11.31M | 31.46M | 46.73M | 38.96M |
| MinorityInterests | -2.16M | -6.05M | -9.01M | -7.51M |
| NetIncomeIncludingNoncontrollingInterests | 13.47M | 37.51M | 55.74M | 46.47M |
| NetIncomeContinuousOperations | 13.47M | 37.51M | 55.74M | 46.47M |
| TaxProvision | 924.00K | 6.25M | 8.17M | 6.60M |
| PretaxIncome | 14.39M | 43.76M | 63.91M | 53.07M |
| OtherIncomeExpense | 1.03M | 234.00K | 550.00K | -1.60M |
| OtherNonOperatingIncomeExpenses | 355.00K | 234.00K | 550.00K | -84.00K |
| SpecialIncomeCharges | -10.05M | -968.00K | -1.52M | |
| WriteOff | 10.05M | 968.00K | 1.52M | |
| GainOnSaleOfSecurity | 679.00K | |||
| NetNonOperatingInterestIncomeExpense | -3.81M | -4.11M | -2.73M | -934.00K |
| InterestExpenseNonOperating | 4.04M | 4.42M | 2.84M | 1.05M |
| InterestIncomeNonOperating | 231.00K | 312.00K | 114.00K | 112.00K |
| OperatingIncome | 17.17M | 47.64M | 66.09M | 55.60M |
| OperatingExpense | 74.12M | 69.87M | 81.79M | 69.79M |
| OtherOperatingExpenses | -733.00K | -2.65M | -255.00K | -1.70M |
| ProvisionForDoubtfulAccounts | -1.78M | -3.71M | 9.73M | 1.93M |
| ResearchAndDevelopment | 12.79M | 11.90M | 13.42M | 11.37M |
| SellingGeneralAndAdministration | 63.84M | 64.33M | 58.89M | 58.19M |
| SellingAndMarketingExpense | 41.27M | 40.74M | 34.56M | 35.90M |
| GeneralAndAdministrativeExpense | 22.57M | 23.59M | 24.32M | 22.29M |
| OtherGandA | 22.57M | 23.59M | 24.32M | 22.29M |
| GrossProfit | 91.30M | 117.51M | 147.88M | 125.39M |
| CostOfRevenue | 95.06M | 94.14M | 112.39M | 88.67M |
| TotalRevenue | 186.36M | 211.65M | 260.27M | 214.07M |
| OperatingRevenue | 173.29M | 204.35M | 251.98M | 214.07M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 47.17M | 47.17M | 47.17M | 47.17M |
| ShareIssued | 47.17M | 47.17M | 47.17M | 47.17M |
| NetDebt | 67.83M | 74.78M | 55.13M | 23.72M |
| TotalDebt | 86.43M | 89.85M | 64.88M | 30.00M |
| TangibleBookValue | 261.18M | 248.37M | 268.59M | 246.72M |
| InvestedCapital | 370.39M | 362.70M | 361.38M | 297.47M |
| WorkingCapital | 41.66M | 39.01M | 62.08M | 39.32M |
| NetTangibleAssets | 261.18M | 248.37M | 268.59M | 246.72M |
| CommonStockEquity | 283.96M | 272.85M | 296.50M | 267.47M |
| TotalCapitalization | 288.76M | 282.84M | 306.49M | 267.47M |
| TotalEquityGrossMinorityInterest | 352.54M | 339.27M | 356.87M | 318.84M |
| MinorityInterest | 68.58M | 66.42M | 60.37M | 51.36M |
| StockholdersEquity | 283.96M | 272.85M | 296.50M | 267.47M |
| GainsLossesNotAffectingRetainedEarnings | 32.65M | 31.31M | 27.57M | 21.99M |
| OtherEquityAdjustments | 32.65M | 31.31M | 27.57M | 21.99M |
| RetainedEarnings | 48.15M | 38.38M | 65.77M | 42.33M |
| AdditionalPaidInCapital | 203.15M | 203.15M | 203.15M | 203.15M |
| CapitalStock | 8.00K | 8.00K | 8.00K | 8.00K |
| CommonStock | 8.00K | 8.00K | 8.00K | 8.00K |
| TotalLiabilitiesNetMinorityInterest | 140.71M | 160.62M | 162.81M | 126.44M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 4.80M | 10.38M | 10.58M | 816.00K |
| TradeandOtherPayablesNonCurrent | 0.00 | 393.00K | 590.00K | 816.00K |
| LongTermDebtAndCapitalLeaseObligation | 4.80M | 9.99M | 9.99M | |
| LongTermDebt | 4.80M | 9.99M | 9.99M | |
| CurrentLiabilities | 135.91M | 150.23M | 152.23M | 125.63M |
| OtherCurrentLiabilities | 556.00K | 841.00K | 886.00K | 869.00K |
| CurrentDeferredLiabilities | 6.41M | 3.98M | 4.70M | 4.28M |
| CurrentDeferredRevenue | 3.69M | 3.98M | 4.70M | 4.28M |
| CurrentDebtAndCapitalLeaseObligation | 81.63M | 79.86M | 54.89M | 30.00M |
| CurrentDebt | 81.63M | 79.86M | 54.89M | 30.00M |
| OtherCurrentBorrowings | 7.19M | 79.86M | 54.89M | 30.00M |
| LineOfCredit | 74.44M | 79.86M | ||
| PayablesAndAccruedExpenses | 47.31M | 65.55M | 91.75M | 90.47M |
| CurrentAccruedExpenses | 99.00K | 10.00K | 10.00K | 310.00K |
| Payables | 47.21M | 65.54M | 91.74M | 90.16M |
| OtherPayable | 2.04M | 1.93M | 2.47M | 2.08M |
| DuetoRelatedPartiesCurrent | 146.00K | 0.00 | ||
| DividendsPayable | 0.00 | 15.65M | 0.00 | 3.71M |
| TotalTaxPayable | 2.07M | 2.29M | 10.00M | 6.81M |
| AccountsPayable | 42.96M | 45.66M | 79.28M | 77.57M |
| TotalAssets | 493.25M | 499.89M | 519.67M | 445.28M |
| TotalNonCurrentAssets | 315.68M | 310.65M | 305.37M | 280.33M |
| NonCurrentPrepaidAssets | 18.70M | 6.50M | 2.23M | 13.17M |
| NonCurrentDeferredAssets | 19.04M | 16.41M | ||
| NonCurrentDeferredTaxesAssets | 10.99M | 11.91M | ||
| GoodwillAndOtherIntangibleAssets | 22.78M | 24.48M | 27.90M | 20.75M |
| OtherIntangibleAssets | 22.78M | 24.48M | 27.90M | 20.75M |
| NetPPE | 255.16M | 263.25M | 275.23M | 246.41M |
| AccumulatedDepreciation | -111.55M | -92.60M | -73.42M | -91.31M |
| GrossPPE | 366.72M | 355.85M | 348.65M | 337.73M |
| ConstructionInProgress | 9.75M | 7.62M | 82.06M | 52.76M |
| OtherProperties | 148.26M | 147.76M | 143.48M | 114.75M |
| MachineryFurnitureEquipment | 3.28M | 3.28M | 3.32M | 3.32M |
| BuildingsAndImprovements | 205.43M | 197.19M | 119.79M | 166.90M |
| LandAndImprovements | 12.86M | 12.86M | 12.86M | |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 177.57M | 189.24M | 214.31M | 164.94M |
| CurrentDeferredAssets | 16.41M | 12.46M | 11.14M | |
| CurrentDeferredTaxesAssets | 11.91M | 12.46M | 11.14M | |
| RestrictedCash | 2.00K | 12.11M | 0.00 | |
| PrepaidAssets | 10.79M | 3.11M | 2.43M | 1.71M |
| Inventory | 58.22M | 58.30M | 55.42M | 43.62M |
| InventoriesAdjustmentsAllowances | -13.39M | -3.36M | -2.84M | |
| FinishedGoods | 17.74M | 14.86M | 13.98M | 10.40M |
| WorkInProcess | 33.05M | 33.57M | 33.89M | 27.02M |
| RawMaterials | 7.43M | 9.87M | 10.91M | 9.04M |
| Receivables | 88.52M | 99.42M | 134.25M | 102.19M |
| OtherReceivables | 2.63M | 1.30M | 672.00K | 489.00K |
| DuefromRelatedPartiesCurrent | 738.00K | 738.00K | 0.00 | |
| NotesReceivable | 25.59M | 23.21M | 30.68M | 18.28M |
| AccountsReceivable | 59.56M | 74.17M | 102.90M | 83.42M |
| AllowanceForDoubtfulAccountsReceivable | -16.87M | -18.62M | -21.38M | -20.17M |
| GrossAccountsReceivable | 76.44M | 92.78M | 124.28M | 103.59M |
| CashCashEquivalentsAndShortTermInvestments | 20.04M | 16.30M | 9.75M | 6.28M |
| OtherShortTermInvestments | 1.43M | 1.22M | 0.00 | |
| CashAndCashEquivalents | 18.60M | 15.07M | 9.75M | 6.28M |
| CashFinancial | 18.60M | 15.07M | 9.75M | 6.28M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 13.27M | 36.58M | -9.99M | 5.41M |
| RepaymentOfDebt | -92.86M | -54.89M | -64.97M | -22.00M |
| IssuanceOfDebt | 90.12M | 79.86M | 99.85M | 30.00M |
| CapitalExpenditure | -27.77M | -11.60M | -27.33M | -26.40M |
| InterestPaidSupplementalData | 3.98M | 4.42M | 2.84M | 1.05M |
| IncomeTaxPaidSupplementalData | 116.00K | 10.49M | 8.48M | 6.99M |
| EndCashPosition | 18.61M | 27.19M | 9.75M | 6.28M |
| BeginningCashPosition | 27.19M | 9.75M | 6.28M | 3.79M |
| EffectOfExchangeRateChanges | 168.00K | 0.00 | 0.00 | |
| ChangesInCash | -8.75M | 17.44M | 3.46M | 2.49M |
| FinancingCashFlow | -22.13M | -18.98M | 13.46M | -3.05M |
| CashFlowFromContinuingFinancingActivities | -22.13M | -18.98M | 13.46M | -3.05M |
| NetOtherFinancingCharges | -3.37M | -4.50M | ||
| CashDividendsPaid | -16.02M | -39.45M | -21.43M | -11.05M |
| CommonStockDividendPaid | -16.02M | -39.45M | -21.43M | -11.05M |
| NetIssuancePaymentsOfDebt | -2.74M | 24.97M | 34.88M | 8.00M |
| NetLongTermDebtIssuance | -2.74M | 24.97M | 34.88M | 8.00M |
| LongTermDebtPayments | -92.86M | -54.89M | -64.97M | -22.00M |
| LongTermDebtIssuance | 90.12M | 79.86M | 99.85M | 30.00M |
| InvestingCashFlow | -27.66M | -11.77M | -27.33M | -26.27M |
| CashFlowFromContinuingInvestingActivities | -27.66M | -11.77M | -27.33M | -26.27M |
| NetInvestmentPurchaseAndSale | 0.00 | -1.22M | 0.00 | |
| PurchaseOfInvestment | 0.00 | -1.22M | 0.00 | |
| NetIntangiblesPurchaseAndSale | -14.19M | -4.20M | 0.00 | -7.34M |
| PurchaseOfIntangibles | -14.19M | -4.20M | 0.00 | -7.34M |
| NetPPEPurchaseAndSale | -13.48M | -6.34M | -27.33M | -18.93M |
| SaleOfPPE | 108.00K | 1.06M | 0.00 | 128.00K |
| PurchaseOfPPE | -13.59M | -7.40M | -27.33M | -19.06M |
| OperatingCashFlow | 41.05M | 48.18M | 17.34M | 31.81M |
| CashFlowFromContinuingOperatingActivities | 41.05M | 48.18M | 17.34M | 31.80M |
| ChangeInWorkingCapital | -977.00K | -20.28M | -66.60M | -33.71M |
| ChangeInOtherWorkingCapital | -400.00K | -715.00K | 317.00K | 1.40M |
| ChangeInOtherCurrentLiabilities | -218.00K | -204.00K | -230.00K | |
| ChangeInPayablesAndAccruedExpense | 1.67M | -44.09M | -6.50M | 18.63M |
| ChangeInAccruedExpense | 2.70M | -582.00K | 207.00K | 521.00K |
| ChangeInPayable | -1.03M | -43.51M | -6.71M | 18.11M |
| ChangeInAccountPayable | -404.00K | -35.61M | -9.67M | 17.63M |
| ChangeInTaxPayable | -229.00K | -7.70M | 3.19M | 801.00K |
| ChangeInIncomeTaxPayable | -229.00K | -7.70M | 3.19M | 801.00K |
| ChangeInPrepaidAssets | -8.96M | -1.18M | -717.00K | -482.00K |
| ChangeInInventory | -5.88M | -12.90M | -12.32M | -12.34M |
| ChangeInReceivables | 12.59M | 38.62M | -47.37M | -40.68M |
| ChangesInAccountReceivables | 16.34M | 31.04M | -24.72M | -28.50M |
| OtherNonCashItems | 2.00K | |||
| UnrealizedGainLossOnInvestmentSecurities | -209.00K | 0.00 | 0.00 | |
| ProvisionandWriteOffofAssets | -1.78M | -3.71M | 9.73M | 1.93M |
| AssetImpairmentCharge | 5.96M | 10.03M | 968.00K | 1.52M |
| DeferredTax | 924.00K | 541.00K | -1.31M | -358.00K |
| DeferredIncomeTax | 924.00K | 541.00K | -1.31M | -358.00K |
| DepreciationAmortizationDepletion | 24.16M | 23.91M | 18.80M | 16.01M |
| DepreciationAndAmortization | 24.16M | 23.91M | 18.80M | 16.01M |
| OperatingGainsLosses | -505.00K | 187.00K | -53.00K | |
| NetForeignCurrencyExchangeGainLoss | -679.00K | 0.00 | 0.00 | |
| GainLossOnSaleOfPPE | 174.00K | 187.00K | 0.00 | -53.00K |
| NetIncomeFromContinuingOperations | 13.47M | 37.51M | 55.74M | 46.47M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for ZYBT
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|